Senators grilled Robert F. Kennedy Jr. on if and how he would reform Medicaid and Medicare during his first confirmation hearing to become the next secretary of Health and Human Services.

The U.S. Food and Drug Administration (FDA) recently issued two new guidance documents governing details of the Accelerated Approval

President Donald Trump’s Day One executive order rescinding Biden-era Medicare and Medicaid price innovation programs signals sweeping changes to the drug and treatment pricing agency within the Centers for Medicare and Medicaid Services and perhaps a substantive shake-up in two of the largest federal social welfare programs.

The final proposed model would have had Medicare pay less for drugs that receive accelerated approvals from the Food and Drug Administration (FDA). The FDA grants accelerated approvals to promising drugs to make them available for patients sooner, ...

Ozempic and Wegovy, the blockbuster but costly GLP-1 drugs often used for weight loss, are among the 15 medications that will be subject to the next round of Medicare price negotiations, the Biden administration announced Friday.

The Biden administration announced Friday that Ozempic, Wegovy and 13 additional drugs will now be covered under Medicare Part-D for price negotiations, the next round of negotiations under the Inflation Reduction Act passed by President Joe Biden in 2022.

The Centers for Medicare and Medicaid Services (CMS) has included Ozempic among the next 15 drugs chosen for Medicare negotiation. The CMS listed Ozempic, Rybelsus and Wegovy — all forms of

In his first Senate confirmation hearing to be secretary of the Department of Health and Human Services, Robert F. Kennedy Jr. repeated claims we have written about before on vaccines and chronic disease.

Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.

Medicare Part D prescription drug plans may cover estradiol cream. A person can check with their plan to confirm coverage.

If he is confirmed as Health and Human Services secretary, Robert F. Kennedy Jr. would take over a sprawling bureaucracy with an annual budget that tops $1.7 trillion, with more than 80,000 employees and 13 divisions.

RFK Jr has long expressed views that conflict with scientific evidence, especially on vaccines, and his nomination has provoked opposition from public health experts. But he has also adopted positions with popular support, scrutinising the use of food additives and urging that the power of big pharma be curbed.